The value #CROs and #CDMOs bring, especially smaller, focused biotechs can sometimes be overlooked. However, a strong symbiotic relationship between companies and their partners is critical to bring new therapies to market. Thanks @Louis_Garguilo!https://www.lifescienceleader.com/doc/i-outsource-therefore-i-exist-0001?vm_tId=2114446&user=57be9c65-5ff3-47de-870a-30bb98fe8e4b&vm_alias=I%2520Outsource,%2520Therefore%2520I%2520Exist&utm_source=mkt_LSL&utm_medium=email&utm_campaign=LSL_03-04-2019&utm_term=57be9c65-5ff3-47de-870a-30bb98fe8e4b&utm_content=I%2520Outsource,%2520Therefore%2520I%2520Exist&mkt_tok=eyJpIjoiT0dJNVltVXlaV1kxT0dGaiIsInQiOiIrWXJxVmN3ejM1c2lhM21tRkJVc1wvRHpJdm5tVFZwRThEY01YU0M4OUcwZ0N2UDB0dlJ3allUTExkeDJzaCt1UjNtaG5WTXdFbHNLV014UGtZbDdqeUNHMUF5ekZBRzRJOXpZdWZZMVJ5UE94cVhHRkpWbzVHWTBSUkkzdEYzajEifQ%253D%253D …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.